Activating Cannabinoid Receptor 2 Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis Via Activation of Autophagy and Inhibiting NLRP 3 Inflammasome
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Summary: Aims: Activation of cannabinoid receptor 2 (CB 2R) has been reported to ameliorate the pathogenesis of experimental autoimmune encephalomyelitis (EAE). In this study, we examined whether autophagy is involved in the beneficial effect of CB 2R on EAE and explored the mechanism with a focus on inflammasome activation. Methods: EAE severity was analyzed with clinical score and histological score stained by hematoxylin and eosin or luxol fast blue in spinal cord. Immunoblot analysis was conducted to detect proteins of NOD‐like receptor family, pyrin domain containing 3 (NLRP 3) inflammasome‐related caspase‐1 (Casp‐1) and the maturation of interleukin (IL)‐1β as well as autophagy‐related light chain 3 (LC3), and Beciln 1 both in vivo and in vitro. Reverse transcription and real‐time PCR were used to detect mRNA of NLRP 3, IL‐1β and Casp‐1. Autophagy‐related gene 5 (ATG 5)‐specific si RNA was transiently transfected in BV 2 microglia, and immunofluorescence staining was carried out to detect the expression of NLRP3, caspase recruitment domain (ASC), and pro‐caspase‐1. Results: The current data indicated that deleting CB 2R decreased the expression of LC 3‐II/LC 3‐I ratio, Beclin 1 and increased caspase‐1 activation and IL‐1β production in the spinal cord of EAE mice, whereas activation of CB 2R with a specific agonist HU‐308 induced inverse effects. Further study indicated that HU‐308 could promote autophagy and inhibit expression and activation of NLRP 3 inflammasome in BV 2 microglia. Blocking autophagy by ATG 5‐specific si RNA dismissed the effort of CB 2R in mediating NLRP 3 inflammasome in vitro. Conclusion: Collectively, our results demonstrated for the first time that CB 2R plays a protective role in EAE through promoting autophagy and inhibiting NLRP 3 inflammasome activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230 · cited 1×
“The important link between autophagy and immunity could be through playing a negative role with respect to inflammasome activation, which is responsible for the activity of caspase-1 (Casp-1) and the maturation of interleukin (IL)-1b and IL-18 [3].”
BackgroundCompston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
Shi, C.-S., Shenderov, K., Huang, N.-N., Kabat, J., Abu-Asab, M., Fitzgerald, K. A., Sher, A., & Kehrl, J. H. (2012) · Nature Immunology · doi:10.1038/ni.2215 · Cited by 1,367
Autophagy Links Inflammasomes to Atherosclerotic Progression
Razani, B., Feng, C., Coleman, T., Emanuel, R., Wen, H., Hwang, S., Ting, J. P., Virgin, H. W., Kastan, M. B., & Semenkovich, C. F. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.02.011 · Cited by 601
Dello Russo, C., Lisi, L., Feinstein, D. L., & Navarra, P. (2013) · Glia · doi:10.1002/glia.22433 · Cited by 96 · cited 1×
“protein aggregation, which lead to reduced inflammatory reaction, apoptosis, and necrosis [38].”
BackgroundZhao, W., Li, Y., Jia, L., Pan, L., Li, H., & Du, J. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.01.002 · Cited by 87
Cited by
NLRP3 inflammasome and its inhibitors: a review
Shao, B.-Z., Xu, Z.-Q., Han, B.-Z., Su, D.-F., & Liu, C. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00262 · Cited by 836
“…et al., 2014; Zhuang et al., 2015), lysosomal disruption (Hornung et al., 2008; Sheedy et al., 2013; Tseng et al., 2013), autophagic dysfunction (Cho et al., 2014; Shao et al., 2014; Jabir et al., 2015) and the activity of thioredoxin-interacting protein (TXNIP; Li et al., 2015; Liu et al., 2015).”
BackgroundInfluentialSelf-citationNew insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD
Larabi, A., Barnich, N., & Nguyen, H. T. T. (2020) · Autophagy · doi:10.1080/15548627.2019.1635384 · Cited by 835
Pharmacological Inhibitors of the NLRP3 Inflammasome
Zahid, A., Li, B., Kombe, A. J. K., Jin, T., & Tao, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02538 · Cited by 671
Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
Uddin, M. S., Stachowiak, A., Mamun, A. A., Tzvetkov, N. T., Takeda, S., Atanasov, A. G., Bergantin, L. B., Abdel-Daim, M. M., & Stankiewicz, A. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00004 · Cited by 395
Martínez, G. J., Celermajer, D. S., & Patel, S. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.12.027 · Cited by 342
Metadata
- Authors
- Shao, B., Wei, W., Ke, P., Xu, Z., Zhou, J., & Liu, C.
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2014-11-24
- Volume
- 20
- Issue
- 12
- Pages
- 1021-1028
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- OpenAlex
- W1981893522
- Cited by
- 131
- References
- 6
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.